Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. BIOTECHNOLOGY Researchers in Iran announce the impending birth of that nation’s first generation of…
Op-Eds
Cardiac arrest at the FDA
The photograph on your Tuesday front page headlined “Hillary health care” shows Sen. Hillary Rodham Clinton, New York Democrat, in Jerusalem holding a CardioPump—a device…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. FOOD SAFETY The Food and Drug Administration is poised to issue guidelines on the sale of…
Op-Eds
Are We in a Brave New World of “Personalized” Medicine?
BiDil, a new drug labeled for treatment of blacks with severe heart failure, has begun to arrive in pharmacies. Approved by FDA in…
Op-Eds
More Crop for the Drop
The worst East Central U.S. drought in almost 20 years is decimating harvests of corn and soybeans, threatening farmers’ economic survival and disrupting commercial shipping…
Op-Eds
‘Big Lie’ Enough to Make Drug Industry Ill
Activism can be a good thing. We all benefit from getting to shop in the marketplace of ideas. However, all is not good-faith activism. Take,…